NCT04493242 Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS Status COMPLETED Phase PHASE2
NCT04492254 Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients Status TERMINATED Phase PHASE3
NCT04491240 Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia. Status COMPLETED Phase PHASE1/PHASE2
NCT04490837 Rapid Diagnostic Test for COVID-19 Based on Antibody Detection (YCOVID) Status COMPLETED Phase N/A
NCT04490811 Seroprevalence and Immunoprotection Against COVID-19 in Parisian Children Status UNKNOWN Phase N/A
NCT04490486 Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19 Status WITHDRAWN Phase PHASE1
NCT04490174 Serological Surveillance for COVID-19 in Central North Carolina Status COMPLETED Phase N/A
NCT04489992 Experiment on the Use of Innovative Computer Vision Technologies for Analysis of Medical Images in the Moscow Healthcare System Status UNKNOWN Phase N/A
NCT04488562 Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands Status COMPLETED Phase N/A
NCT04488484 Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2. Status COMPLETED Phase NA
NCT04488081 I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04487886 Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19) Status COMPLETED Phase PHASE2
NCT04487210 A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19 Status COMPLETED Phase PHASE1
NCT04486313 Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19 Status COMPLETED Phase PHASE3
NCT04485429 Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia Status WITHDRAWN Phase PHASE3
NCT04485169 Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm; Status COMPLETED Phase NA